Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Star Navigation: Bridging the gap between flight experience and flight safety in real-time

Star Navigation bridges the gap between flight experience and flight safety in real time. When it comes to the aerospace industry, the Ontario-based leading-edge technology company offers both hardware and software solutions. The company’s real-time ca...
Simon Druker | November 2, 2022 |

Video – A2Z Revolutionizes Car Safety with FTICS

FTICS movie v1 from A2Z Technologies Canada Corp on Vimeo . Many life-changing product innovations have come from militaries, and A2Z Technologies Canada Corp. ( TSX-V:AZ , Forum ) is using their 30-year history of supplying military defense technology and service...
Featured Submission | January 15, 2020 |

Calibre Has Some Safety in the Storm

Last week provided a glimpse into the future of the stock market. Only a glimpse. It is going to get a whole lot worse. On January 1, I said in an article I titled Beware the Stock Market , " As the Everything Bubble pops, the financial system will destroy most inves...
Streetwise Reports | March 2, 2020 |

The 10 Highest Paying Jobs In Oil & Gas

Make no mistake: Oil and gas companies may be doing some serious cost-cutting and slimming-and-trimming to stay competitive after the shale boom binge, but when it comes to employment, it's still one of the best industries to hit up for a job. Jobs are booming, just as m...
Julianne Geiger | November 12, 2019 |

Relmada Therapeutics Stock Soars on Phase 2 Depression Study Results

Shares of Relmada Therapeutics have traded wildly today after it announced Phase 2 results for its anti-depressant drug dextromethadone. The firm's shares have traded 100–200% higher today and the stock was halted several times trading due to extreme price volatility. ...
Streetwise Reports | October 16, 2019 |

New Covid-19 Highs, New Major Price Moves

The second wave of Covid-19 is here and while it makes gold’s potential even better in the long run, it’s likely to mean a sharp decline beforehand. It might be tempting to focus on something else, to look the other way, or to limit testing,...
Przemyslaw Radomski, CFA | June 29, 2020 |

A Bold Innovator in Tactical & Defense Security

(Image via KWESST Inc.) KWESST Inc. ( TSX-V: FMV.P ) is a Canadian military tech Company that “makes dumb weapons smart” by developing proprietary technology for the military and homeland security markets. Its Executive Chairman David Luxton wa...
Featured Submission | September 9, 2020 |

Buzz on the Bullboards: Lost in the smoke

From East to West, wildfire smoke has blanketed the skies in smog, forcing people to inhale some of the worst smog on Earth and prompting air quality advisories. Flights and sporting events have been postponed and many find themselves searching for their old COVID mas...
Jonathon Brown | June 8, 2023 |

Regeneron Reports Positive Phase 3 Dupixent Data; Gains EU Approval Recommendation

Regeneron Pharmaceuticals published positive results from two U.S. Phase 3 trials evaluating the safety and efficacy of Dupixent (dupilumab) in adults with recurring severe chronic rhinosinusitis with nasal polyps. The European Medicines Agency's Committee for Medicinal Produc...
Streetwise Reports | September 24, 2019 |

The Russell and Transportation Tell A Completely Different Story

We've been writing about the broader US stock market for many months – highlighting the Pennant/Flag formations that have continued to set up since early 2018. Sometimes, the keys to really understanding what is transpiring behind the scenes in the US markets is to pay attenti...
Chris Vermeulen | October 7, 2019 |
1 2 3 4 5 6 7 8 9 10 ...